Buy

VRTX Quote, Financials, Valuation and Earnings

Last price:

$503.08

Seasonality move :

11.41%

Day range:

$501.07 - $510.08

52-week range:

$377.85 - $519.88

Dividend yield:

0%

P/E ratio:

26.10x

P/S ratio:

11.84x

P/B ratio:

7.87x

Volume:

2.3M

Avg. volume:

1.4M

1-year change:

21.05%

Market cap:

$129.2B

Revenue:

$11B

EPS (TTM):

-$2.20

Vertex Pharmaceuticals SEC Filings

Company	Filed	Form Type	Description
VRTX Vertex Pharmaceuticals	05/07/2024	10-Q	10-Q filing on 05/07/2024	View Form
VRTX Vertex Pharmaceuticals	02/15/2024	10-K	10-K filing on 02/15/2024	View Form
VRTX Vertex Pharmaceuticals	11/07/2023	10-Q	10-Q filing on 11/07/2023	View Form
VRTX Vertex Pharmaceuticals	08/02/2023	10-Q	10-Q filing on 08/02/2023	View Form
VRTX Vertex Pharmaceuticals	05/02/2023	10-Q	10-Q filing on 05/02/2023	View Form
VRTX Vertex Pharmaceuticals	02/10/2023	10-K	10-K filing on 02/10/2023	View Form
VRTX Vertex Pharmaceuticals	10/28/2022	10-Q	10-Q filing on 10/28/2022	View Form
VRTX Vertex Pharmaceuticals	08/05/2022	10-Q	10-Q filing on 08/05/2022	View Form
VRTX Vertex Pharmaceuticals	05/06/2022	10-Q	10-Q filing on 05/06/2022	View Form
VRTX Vertex Pharmaceuticals	02/09/2022	10-K	10-K filing on 02/09/2022	View Form
VRTX Vertex Pharmaceuticals	11/03/2021	10-Q	10-Q filing on 11/03/2021	View Form
VRTX Vertex Pharmaceuticals	07/30/2021	10-Q	10-Q filing on 07/30/2021	View Form
VRTX Vertex Pharmaceuticals	04/30/2021	10-Q	10-Q filing on 04/30/2021	View Form
VRTX Vertex Pharmaceuticals	02/11/2021	10-K	10-K filing on 02/11/2021	View Form
VRTX Vertex Pharmaceuticals	10/30/2020	10-Q	10-Q filing on 10/30/2020	View Form
VRTX Vertex Pharmaceuticals	07/31/2020	10-Q	10-Q filing on 07/31/2020	View Form
VRTX Vertex Pharmaceuticals	05/01/2020	10-Q	10-Q filing on 05/01/2020	View Form
VRTX Vertex Pharmaceuticals	02/13/2020	10-K	10-K filing on 02/13/2020	View Form
VRTX Vertex Pharmaceuticals	10/31/2019	10-Q	10-Q filing on 10/31/2019	View Form
VRTX Vertex Pharmaceuticals	08/01/2019	10-Q	10-Q filing on 08/01/2019	View Form
VRTX Vertex Pharmaceuticals	05/01/2019	10-Q	10-Q filing on 05/01/2019	View Form
VRTX Vertex Pharmaceuticals	02/13/2019	10-K	10-K filing on 02/13/2019	View Form
VRTX Vertex Pharmaceuticals	10/25/2018	10-Q	10-Q filing on 10/25/2018	View Form
VRTX Vertex Pharmaceuticals	07/26/2018	10-Q	10-Q filing on 07/26/2018	View Form
VRTX Vertex Pharmaceuticals	04/27/2018	10-Q	10-Q filing on 04/27/2018	View Form
VRTX Vertex Pharmaceuticals	02/15/2018	10-K	10-K filing on 02/15/2018	View Form
VRTX Vertex Pharmaceuticals	10/30/2017	10-Q	10-Q filing on 10/30/2017	View Form
VRTX Vertex Pharmaceuticals	07/28/2017	10-Q	10-Q filing on 07/28/2017	View Form
VRTX Vertex Pharmaceuticals	04/28/2017	10-Q	10-Q filing on 04/28/2017	View Form
VRTX Vertex Pharmaceuticals	02/23/2017	10-K	10-K filing on 02/23/2017	View Form
VRTX Vertex Pharmaceuticals	10/31/2016	10-Q	10-Q filing on 10/31/2016	View Form
VRTX Vertex Pharmaceuticals	08/01/2016	10-Q	10-Q filing on 08/01/2016	View Form
VRTX Vertex Pharmaceuticals	05/03/2016	10-Q	10-Q filing on 05/03/2016	View Form
VRTX Vertex Pharmaceuticals	02/16/2016	10-K	10-K filing on 02/16/2016	View Form
VRTX Vertex Pharmaceuticals	10/30/2015	10-Q	10-Q filing on 10/30/2015	View Form
VRTX Vertex Pharmaceuticals	08/04/2015	10-Q	10-Q filing on 08/04/2015	View Form
VRTX Vertex Pharmaceuticals	05/04/2015	10-Q	10-Q filing on 05/04/2015	View Form

Related Companies

Get VRTX Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

VRTX

Sector

P/E ratio

26.10x

24.27x

PEG ratio

1.15x

0.00x

P/B ratio

7.87x

1.71x

Price / LTM sales

11.84x

1.71x

Growth Metrics

VRTX

Sector

Revenue growth

15.66%

6.42%

Earnings growth

-5.66%

6.3%

Revenue (5-year growth)

21.5%

8.99%

Earnings forecast

$4.02

-$0.20

Profitability

VRTX

Sector

Profitability FY 2024

$9.5B

$56.6M

Return on invested capital

-3.23%

-14.62%

Return on assets

-2.4%

-11.82%

Return on equity

-3.23%

-16.83%

Earnings Date

Last Earnings Date

Feb

10

Next Earnings Date

May

6

Estimated Next Earnings Date

May

12

Balance Sheet

VRTX

Sector

Total cash

$6.1B

$42.2M

Short term investments

$1.5B

$37.8M

Total assets

$22.5B

$127.4M

Long term debt

--

$9.7M

Stock Ideas

Buy

55

Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy or Sell?

Buy

53

Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy or Sell?

Buy

51

Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Buy or Sell?

Alerts

Sell

50

RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Buy or Sell?

Sell

36

VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy or Sell?

Buy

61

ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Vertex Pharmaceuticals SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get VRTX Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon Stock Still Worth Staking On?

Is Palantir a Good Stock to Buy?

Why Is Sportradar Stock Going Up?

Stock Ideas

Is AAPL Stock a Buy?

Is MSFT Stock a Buy?

Is NVDA Stock a Buy?

Alerts

RGC alert for Mar 22

VMI alert for Mar 22

ALNY alert for Mar 22

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS